167
Views
3
CrossRef citations to date
0
Altmetric
Original Article

Is there a difference in clinicopathological outcomes of renal tumor between young and old patients? A multicenter matched-pair analysis

, , , , &
Pages 387-391 | Received 08 Jan 2016, Accepted 14 Jun 2016, Published online: 14 Jul 2016
 

Abstract

Objective: The aim of this study was to investigate the influence of age at diagnosis on tumor characteristics and cancer-specific survival (CSS) in renal cell carcinoma (RCC).

Materials and methods: Data of patients who underwent radical or partial nephrectomy for renal tumor between 2003 and 2011 at multiple institutions were collected. Patients were divided into two groups according to age at diagnosis: 20–39 years and 40–79 years. To adjust for potential baseline confounders, propensity score matching was performed.

Results: All included data showed that young RCC patients presented with renal tumors that had a more favorable histological subtype, were localized, smaller in size, and had a lower Fuhrman nuclear grade. The 5 year CSS rates were 95.5% and 90.5% in the young and old patient groups, respectively (log rank p = 0.019). After matching on the propensity score, the two groups with RCC had 302 patients each. Because the groups were matched on covariates, there were no significant differences in the pathological proportion, tumor size, Fuhrman nuclear grade and clinical T stage. The 5 year CSS rates were 95.5% and 94.7% in the young and old patient groups, respectively (log rank p = 0.184).

Conclusion: After adjusting for potential biases, there was no significant difference in prognosis between young and old patients with RCC.

Disclosure statement

The authors declare that they have no conflict of interest.

Ethical standard

This study was approved by the appropriate Institutional Review Board at our hospital and performed according to the ethical standards laid down by the 1964 Declaration of Helsinki and its later amendments.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.